Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Multigrip
- Development stage
- Phase 3
- Lead developer
- Multilab Indústria e Comércio de Produtos Farmacêuticos
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Multigrip is a best-selling over-the-counter (OTC) cold and flu remedy, originally developed and marketed by the Brazilian drugmaker Multilab Industria e Comercio de Produtos Farmaceuticos. It is a combination drug containing Acetaminophen (an analgesic and antipyretic), Chlorpheniramine Maleate (an antihistamine), and Phenylephrine Hydrochloride (a nasal decongestant). Takeda Pharmaceutical Company acquired Multilab, including the Multigrip brand, to strengthen its position in the Brazilian market for branded generics and OTC products.
- Brand names
- Multigrip
02
Targets
ADRA1A (α1A)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Multigrip.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Multigrip.